HSKA(Delisted)
HeskaยทNASDAQ
--
--(--)
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About HSKA
Heska Corporation
A leading global provider of advanced veterinary diagnostic and specialty solutions
3760 Rocky Mountain Avenue
, Loveland
, Colorado 80538
--
Heska Corporation was originally incorporated in California in 1988 and subsequently in Delaware in 1997. The company's business is comprised of two reporting divisions, Core Companion Animal Health, and other vaccines, pharmaceuticals and products. The Core Companion Animal Health Division (CCA) includes diagnostic instruments and supplies primarily for dogs and cats, as well as single-use diagnostic and other tests, vaccines and pharmaceuticals. The company's products are sold directly to veterinarians by itself and its distributors. The Other Vaccines, Medicines and Products segment (OVP) includes the production of privately labeled vaccines and pharmaceuticals primarily for livestock and other animals including small mammals and fish. All OVP division products are labeled by third parties and sold by third parties.
Company Financials
EPS
HSKA has released its 2023 Q1 earnings. EPS was reported at 0.17, versus the expected -0.5, beating expectations. The chart below visualizes how HSKA has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
HSKA has released its 2023 Q1 earnings report, with revenue of 62.38M, reflecting a YoY change of -3.73%, and net profit of -10.13M, showing a YoY change of -1.39%. The Sankey diagram below clearly presents HSKA's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
No Data
You can ask Aime
No Data
